| Date | Source | Headline |
|---|---|---|
| 22nd Dec 2025 6:00 am | RNS-R | Ipsen expands early development pipeline with Simcere Zaiming's innovative antibody drug conjugate |
| 19th Dec 2025 6:00 am | RNS-R | Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP) |